Copyright Reports & Markets. All rights reserved.

Global Gynecology Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gynecology Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Hormonal Therapy
      • 1.4.3 Non-hormonal Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Gynecology Drugs Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gynecology Drugs Market Size
    • 2.2 Gynecology Drugs Growth Trends by Regions
      • 2.2.1 Gynecology Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Gynecology Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gynecology Drugs Market Size by Manufacturers
      • 3.1.1 Global Gynecology Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gynecology Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gynecology Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gynecology Drugs Key Players Head office and Area Served
    • 3.3 Key Players Gynecology Drugs Product/Solution/Service
    • 3.4 Date of Enter into Gynecology Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gynecology Drugs Market Size by Type (2014-2019)
    • 4.2 Global Gynecology Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gynecology Drugs Market Size (2014-2019)
    • 5.2 Gynecology Drugs Key Players in United States
    • 5.3 United States Gynecology Drugs Market Size by Type
    • 5.4 United States Gynecology Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Gynecology Drugs Market Size (2014-2019)
    • 6.2 Gynecology Drugs Key Players in Europe
    • 6.3 Europe Gynecology Drugs Market Size by Type
    • 6.4 Europe Gynecology Drugs Market Size by Application

    7 China

    • 7.1 China Gynecology Drugs Market Size (2014-2019)
    • 7.2 Gynecology Drugs Key Players in China
    • 7.3 China Gynecology Drugs Market Size by Type
    • 7.4 China Gynecology Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Gynecology Drugs Market Size (2014-2019)
    • 8.2 Gynecology Drugs Key Players in Japan
    • 8.3 Japan Gynecology Drugs Market Size by Type
    • 8.4 Japan Gynecology Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gynecology Drugs Market Size (2014-2019)
    • 9.2 Gynecology Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Gynecology Drugs Market Size by Type
    • 9.4 Southeast Asia Gynecology Drugs Market Size by Application

    10 India

    • 10.1 India Gynecology Drugs Market Size (2014-2019)
    • 10.2 Gynecology Drugs Key Players in India
    • 10.3 India Gynecology Drugs Market Size by Type
    • 10.4 India Gynecology Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gynecology Drugs Market Size (2014-2019)
    • 11.2 Gynecology Drugs Key Players in Central & South America
    • 11.3 Central & South America Gynecology Drugs Market Size by Type
    • 11.4 Central & South America Gynecology Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gynecology Drugs Introduction
      • 12.1.4 Pfizer Revenue in Gynecology Drugs Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Roche
      • 12.2.1 Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gynecology Drugs Introduction
      • 12.2.4 Roche Revenue in Gynecology Drugs Business (2014-2019)
      • 12.2.5 Roche Recent Development
    • 12.3 AbbVie
      • 12.3.1 AbbVie Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gynecology Drugs Introduction
      • 12.3.4 AbbVie Revenue in Gynecology Drugs Business (2014-2019)
      • 12.3.5 AbbVie Recent Development
    • 12.4 Bayer
      • 12.4.1 Bayer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gynecology Drugs Introduction
      • 12.4.4 Bayer Revenue in Gynecology Drugs Business (2014-2019)
      • 12.4.5 Bayer Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gynecology Drugs Introduction
      • 12.5.4 Merck Revenue in Gynecology Drugs Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Abbott Laboratories
      • 12.6.1 Abbott Laboratories Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Gynecology Drugs Introduction
      • 12.6.4 Abbott Laboratories Revenue in Gynecology Drugs Business (2014-2019)
      • 12.6.5 Abbott Laboratories Recent Development
    • 12.7 GlaxoSmithKline
      • 12.7.1 GlaxoSmithKline Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Gynecology Drugs Introduction
      • 12.7.4 GlaxoSmithKline Revenue in Gynecology Drugs Business (2014-2019)
      • 12.7.5 GlaxoSmithKline Recent Development
    • 12.8 Johnson & Johnson
      • 12.8.1 Johnson & Johnson Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Gynecology Drugs Introduction
      • 12.8.4 Johnson & Johnson Revenue in Gynecology Drugs Business (2014-2019)
      • 12.8.5 Johnson & Johnson Recent Development
    • 12.9 Sanofi
      • 12.9.1 Sanofi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Gynecology Drugs Introduction
      • 12.9.4 Sanofi Revenue in Gynecology Drugs Business (2014-2019)
      • 12.9.5 Sanofi Recent Development
    • 12.10 Novartis
      • 12.10.1 Novartis Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Gynecology Drugs Introduction
      • 12.10.4 Novartis Revenue in Gynecology Drugs Business (2014-2019)
      • 12.10.5 Novartis Recent Development
    • 12.11 Eli Lilly
    • 12.12 AstraZeneca
    • 12.13 Allergan
    • 12.14 Amgen
    • 12.15 Chengdu Enwei Group

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Gynecology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gynecology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gynecology Drugs development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Roche
      AbbVie
      Bayer
      Merck
      Abbott Laboratories
      GlaxoSmithKline
      Johnson & Johnson
      Sanofi
      Novartis
      Eli Lilly
      AstraZeneca
      Allergan
      Amgen
      Chengdu Enwei Group

      Market segment by Type, the product can be split into
      Hormonal Therapy
      Non-hormonal Therapy

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gynecology Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Gynecology Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gynecology Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now